Introduction
The integrity of a tissue is maintained in many ways, but foremost among these are the interactions of cells with one another and with the extracellular matrix (ECM) in which they are found. In adult tissue, where a situation of relative stability exists, there is little requirement for cells to move from one location to another -except to meet the needs of normal tissue turnover. However, after tissue damage there is migration of cells from the surrounding tissue to the area of wounding, to effect the repair and healing processes required to reestablish normal tissue function. Similarly, during development from the embryonic stages to the adult form there is extensive temporally and spatially programmed migration and relocation of cells to generate the appropriate tissues and organs. Primary tumour cells often display a fetal phenoAbbreviations used: ECM; extracellular matrix; MMP, matrix metalloproteinase; PG. proteoglycan; TIMP tissue inhibitor of metalloproteinases; NCAM, neural celladhesion molecule; RGD, arginine-glycine-aspartic acid; PMN, polymorphonuclear.
type with differing modes of invasion into normal tissues, and the phenomenon of metastasis is a regular occurrence. This process requires the emigration of cells from the primary tumour, entry to the vascular system, transport via the blood supply and re-entry into tissues through the blood vessel basement membrane to establish a secondary tumour, often remote from the primary site. In many instances it is the metastases which prove fatal and therefore it is imperative that a better understanding of the mechanisms of cell release and migration is gained so that effective intervention therapies may be developed in this area of tumour biology.
Metastasis must involve at least two changes in cell behaviour. First, the affinity which cells may have, either for each other or for the ECM, must decrease to allow the release of cells from the primary tumour. Secondly, the processes of cell migration must require degradation of the surrounding matrix by the local production of proteolytic enzymes. W e shall briefly present some recent evidence which suggests that the two processes may be linked.
Matrix metalloproteinases
Several distinct proteolytic pathways can be cited as a means of effecting the degradation of ECM proteins in situations such as development and growth, wound healing and inflammation, and in tumour invasion and metastasis [I] . Such routes include the plasmin-dependent pathway, the polymorphonuclear (PMN) leucocyte serine proteinase-dependent pathway and the matrix metalloproteinase (MMP)-dependent pathway. This brief review will be confined to features of the MMP pathway and the reader is referred to reviews concerning the alternative modes of degradation [2- (FN) , PG core protein, collagen types IV, V, IX, and X, laminin (LN), and elastin, and can activate procollagenase (proMMP-1). The gelatinases (MMP-2 and MMP-9) can cleave gelatin, collagen types IV, V, VII, X and XI, elastin, fibronectin and PG core protein [ 1 J. Although the interstitial collagenase (MMP-1) has been the most studied of the MMP family, the 72 kDA gelatinase (MMP-2) has been identified as a secreted product from a variety of cell types. The 92 kDa gelatinase is less widespread. All the metalloproteinases are secreted as proenzymes and form a tight association with tissue inhibitors of metalloproteinases (TIMPs); MMP-9 associates with TIMP-1, and MMP-2 with TIMP-2 [6]. This important point should be borne in mind when assessing gelatin zymograms (for the relative levels of gelatinase secretion by cells in vitro) as SLWPAGE, inherent in the technique of zymography, separates the gelatinase from its inhibitor before substrate degradation [7] . Although secretion of the gelatinase may be elevated for a particular cell line, the net activity of the enzyme may be inhibited by a concomitant rise in TIMP produc- Table t Metalloproteinases and their substrates tion. An assessment of net activity in cell-conditioned medium requires the application of a substrate degradation assay [8] .
The gelatinases have been intensively studied because increased levels of these enzymes are secreted by tumour cells that are deemed to possess a high metastatic potential [9] . Such studies have employed artificial or reconstituted basement membranes, amniotic basement membranes or Royden chamber assays to mimic the invasion of the blood vasculature, considered to be an early event in the metastatic process. The fact that the gelatinases can cleave pepsin-solubilized collagen type IV (a basement membrane component) makes the degradation of the basement membrane an attractive assay in vitro, although it has been demonstrated that intact collagen type IV is resistant to digestion by these enzymes [lo] . Nevertheless, other basement membrane proteins are also susceptible to cleavage by gelatinases (fibronectin, PG core protein) and may be the true substrates in vivo. The 72 kDa gelatinase, isolated from the conditioned medium of rat glioma cells, has the ability to degrade aggregates of normal fetal rat brain cells [ 11, 121. The pattern of degradation seen in this system was similar to that obtained when fetal brain cell aggregates were confronted by tumour cell spheroids from which the metalloproteinase was isolated [ 12, 131. It is clear that, irrespective of either the nature of the true substrate or considerations of secreted metalloproteinase inhibitors, the elevated expression of the gelatinases by tumour cells is strongly associated with a metastatic phenotype.
Cell-adhesion molecules
Cell-adhesion molecules can be divided roughly into cell-matrix and cell-cell adhesion molecules, but there is an increasing body of evidence which shows that the molecules do not fall exclusively into one classification and that many of them perform both functions. The families of adhesion molecules can be grouped into the integrins, the immunoglobulin superfamily, the cadherins and the selectins [14] . We shall confine this discussion to the integrins, the cadherins and the immunoglobulin superfamily, and to their link with tumour invasion and the expression of metalloproteinases. Integrin function can be disrupted or inhibited by treating the cells with monoclonal antibodies directed against specific subunits, or by RGD-containing peptides [19] . These have proved to be powerful tools in the elucidation of some of the functions of the integrins. In particular, such experiments have indicated that integrins play an important part in the metastatic behaviour of tumour cells. The a,.B3 integrin binds to vitronectin; its increased expression has been associated with invasive melanoma [ZO, 211. The incubation of A375M, an a, P,-expressing human melanoma cell line, with either anti-a, monoclonal antibodies or with soluble vitronectin, had the effect of increasing the invasive capacity of these cells in vitro through Matrigel barriers [ 201. The increased invasion was accompanied by an increase in the expression of a 72 kDa type IV collagenase (MMP-2). Similarly, studies in which a synthetic peptide of an amino acid sequence contained within the laminin A-chain was incubated with the melanoma cell line B 16F 10 further enhanced the lung colonization (metastatic behaviour) in C57RIJ6 mice [21] through the interaction with a,& integrin. This peptide also produced a dose-dependent increase in type IV collagenase activity secreted by peptide-treated cells in vitro. Further evidence of the importance of the a,/?, integrin in metastasis was obtained from studies on M21 human melanoma cell line from which stable variants (M21-I,) were selected. These failed to express a , chains and, as a consequence, did not express the a,& integrin. These cells were less tumourigenic when injected into athymic nude mice. The stable transfection of the a,-deficient cells with cDNA encoding the a , chain restored the functional expression of the aJ3 integrin, and the tumourigenic behaviour returned to the levels seen with the original M21 parent line [22] . However, rabbit synovial fibroblasts, incubated with a monoclonal antibody directed against the p,-subunit of the fibronectin receptor, failed to increase the expression of type IV collagenase, whereas a stimulation of collagenase (MMP-1) and stromelysin (MMP-3) was observed [23] . This suggests that signal-transduction pathways, elicited by soluble ECM components, or specific integrin ligation may result in the expression of different end-products.
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The cadherins
This group of cell-adhesion molecules is assumed to be the most important in terms of cell-cell adhesion [24] , as the inactivation of the other cell-adhesion systems has little effect on cell adhesion provided that the cells under study have the capability of expressing cadherins. The binding of cells via these proteins is homophilic (i.e. the binding occurs between two cadherin molecules on adjacent cells) and is dependent on the presence of Ca2+. A large body of evidence has indicated that the loss of E-cadherin from carcinoma cells, whether through impaired cadherin function or by lack of expression, leads to a more invasive and metastatic phenotype [25] . Well-differentiated cells were stained positively for E-cadherin in immunostained tumour sections, while less well-differentiated carcinomas were lightly or negatively stained. Single tumour cells remote from the main tumour mass showed no positive E-cadherin staining. Little work has been done to demonstrate an inverse relationship between E-cadherin expression and metalloproteinase production in regard to metastasis, as has been shown to occur in the case of integrins (see above).
The immunoglobulin superfamily
This family of cell-adhesion molecules primarily provides a recognition function at the cell surface through Ca2+-independent binding. The binding displayed in this family can be both homophilic or heterophilic as evidenced, in particular, by neural cell-adhesion molecule (NCAM) which provides for homophilic intercellular adhesion and can provide heterophilic attachment to ECM proteins [26, 271 . NCAM, a glycoprotein, is composed of three polypeptides NCAM-A, NCAM-B and NCAM-C with molecular mass 180 kDa, 140 kDa and 120 kDa, respectively. The A and B proteins are phosphorylated, integral membrane proteins, while C is a nonphosphorylated peripheral polypeptide linked to the plasma membrane by a phosphatidylinositol anchor [28, 291. (Figure l) , forming tumour cell aggregates in non-adherent nutrient agar overlay culture, while parent line and control clones failed to adhere to one another. In summary, the transfection with NCAM restored the BT4Cn line to a phenotype reminiscent of the BT4C line and this was reflected in a decreased motility of transfected cells in a Boyden chamber assay, through a Matrigel substrate, compared with the untransfected BT4Cn line which was significantly more mobile. It was observed that the untransfected line was able to lyse collagen gels in &YO, suggesting an inherent production of proteolytic enzymes. This ability was lost after NCAM gene transfection. Zymography and substrate gel analyses of conditioned media demonstrated that for six NCAM-B transfected clones, the level of 92 kDa gelatinase (MMP-9) was markedly reduced (Figure 2 ), although 72 kDa gelatinase (MMP-2) was unaffected. Control and NCAM-C transfectants secreted both of the gelatinases at levels similar to the parent (BT4Cn) line. Interstitial collagenase (MMP-1) was similarly down-regulated by NCAM-B transfection, being absent in NCAM-B expressors but present in NCAM-C clones (control or parent line) although at low basal levels. These findings suggest that the transmembrane domain of the NCAM molecule, but not the extracellular domain, may be involved in signal transduction, Analysis was by gelatin substrate zymography [7] using 25 pl of conditioned medium ( 5 X lo6 cells in 10 ml of medium for 48 h).
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Conclusions
A clear link between integrin-mediated expression of metalloproteinases has been established and linked to the metastatic behaviour of melanoma cells. The cadherins have also been specifically linked with metalloproteinase secretion. We have demonstrated that NCAM (a member of the immunoglobulin superfamily) mediates metalloproteinase expression and significantly alters the invasive and adhesive properties of tumour cells. Whether such a regulation is a fundamental process in fetal development, where cell migration is a well-recognized phenomenon, has yet to be established.
leading to the control of the expression of the MMP-1 and MMP-9 metalloproteinases. During migratory events in embryogenesis, NCAM is down-regulated, with re-expression occurring once the target organ has been reached and differentiation initiated [ 3 13 . It is not clear whether these events are accompanied by up-regulation of MMP-1 and MMP-9, but a similar NCAM regulation of MMP production would appear to fit well with these developmental processes.
